logo
  • About us
    • In brief
    • The Board of Directors
    • Management Team
    • Corporate Governance
    • Intellectual Properties
    • Partnerships
    • Environment & quality
    • Organization
    • Career
  • Project portfolio
    • Project overview
    • Research areas
    • Development phases
    • Publications
  • Contract research
    • Autoradiography
    • Pharmacokinetics
    • Analytical chemistry
    • Disease models
  • Investor info
    • Contacts
    • Press releases
    • Stock
    • Interim reports
    • Annual reports
    • Presentations
    • Ownership
    • Official documents
    • Calendar
  • Press & news
    • Press releases
    • Interim reports
    • Annual reports
    • Features
    • Image bank
    • Calendar
    • Contacts
  • Contact
    • Visit us
rss RSS
font size decrease font increase font
Project portfolio
  • Project overview
    • Laquinimod
    • ANYARA
    • TASQ
    • 57-57
    • RhuDex™
  • Research areas
  • Development phases
  • Publications
Print

Project overview

As of May 29, 2013.

Active Biotech at the Jefferies 2013 Global Healthcare Conference

Listen to the presentation - June 4 at 4 pm EDT (10 pm CEST) >>

Tasquinimod presented at 2013 ASCO Annual Meeting

View the poster here >>

ANYARA presented at 2013 ASCO Annual Meeting

View the poster here >>

Annual General Meeting - May 15, 2013

Annual Report 2012

Subscribe to press releases from Active Biotech

Read more >>
Active Biotech AB, Scheelevägen 22, P.O. Box 724, SE-220 07 Lund, Sweden, Telephone +46 46 19 20 00